These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 645513)

  • 21. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
    Olley PM; Coceani F
    Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic maintenance of the ductus arteriosus.
    Freed MD
    Conn Med; 1982 Mar; 46(3):131-4. PubMed ID: 7075183
    [No Abstract]   [Full Text] [Related]  

  • 26. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the pediatric field--arteries and prostaglandins].
    Honda S
    Nihon Rinsho; 1985 Mar; 43(3):603-7. PubMed ID: 3892092
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical treatment of the ductus arteriosus.
    Rudolph AM; Heymann MA
    Hosp Pract; 1977 Feb; 12(2):57-65. PubMed ID: 557025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML
    Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical manipulation of the ductus arteriosus.
    Elliott RB; Starling MB; Neutze JM
    Lancet; 1975 Jan; 1(7899):140-2. PubMed ID: 46053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal manipulation--a note of caution.
    Sharpe GL; Altshuler G
    J Pediatr; 1977 Feb; 90(2):335-7. PubMed ID: 830938
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic advances in pediatric cardiology.
    Kaplan S; Gaum WE; Benzing G; Meyer RA; Schwartz DC
    Pediatr Clin North Am; 1978 Nov; 25(4):891-907. PubMed ID: 366528
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological contraction of the ductus arteriosus (author's transl)].
    Momma K
    Kokyu To Junkan; 1981 Oct; 29(10):1026-34. PubMed ID: 7036305
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patent ductus arteriosus: experimental aspects.
    Mott JC
    Arch Dis Child; 1980 Feb; 55(2):99-105. PubMed ID: 6769398
    [No Abstract]   [Full Text] [Related]  

  • 35. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.
    Silver MM; Freedom RM; Silver MD; Olley PM
    Hum Pathol; 1981 Dec; 12(12):1123-36. PubMed ID: 7199511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin and damage to ductus arteriosus.
    Moulaert AJ; Gittenberger AC; Harinck E
    Lancet; 1977 Mar; 1(8013):703-4. PubMed ID: 66503
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.
    Freed MD; Heymann MA; Lewis AB; Roehl SL; Kensey RC
    Circulation; 1981 Nov; 64(5):899-905. PubMed ID: 7285305
    [No Abstract]   [Full Text] [Related]  

  • 39. Patency of the ductus arteriosus in the newborn--now you want it, now you don't.
    Hansen TW
    Pediatr Crit Care Med; 2007 May; 8(3):302-3. PubMed ID: 17496520
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of prostaglandins and prostaglandin inhibitors in critically ill neonates.
    Cohen MA
    MCN Am J Matern Child Nurs; 1983; 8(3):194-9. PubMed ID: 6405117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.